4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-064184
Director sold 1,560 shares at $17.82 ($27,799)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myriam Curet Director | 2020-12-15 | Sale | −1,560 | $17.82 | $27,799 | 19,240 | D: show line 1 in the form |
| Open-market sales · 1,560 sh · avg $17.82 · $27,799 | |||||||
Loading xslF345X03/doc4.xml…